Lv1
30 积分 2026-07-18 加入
Beneficial Effect of Rituximab in the Treatment of Recurrent Idiopathic Membranous Nephropathy after Kidney Transplantation
1个月前
已完结
Dual benefit of belimumab in post-transplant lupus nephritis: Glucocorticoid withdrawal and extrarenal disease control
1个月前
已完结
Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor
1个月前
已关闭
Obinutuzumab for Recurrent FSGS After Kidney Transplantation: A Case of Durable Partial Remission
1个月前
已关闭
Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab
1个月前
已完结
Rituximab as a Preemptive Treatment to Prevent Recurrence of Primary Focal Segmental Glomerulosclerosis: A Novel Approach
1个月前
已关闭
Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant
1个月前
已关闭
Subcutaneous ofatumumab in recurrent focal segmental glomerulosclerosis after kidney transplantation
1个月前
已完结
皖公网安备34019202002308
